Characterization of Neutralizing Human Anti-Tetanus Monoclonal Antibodies Produced by Stable Cell Lines
Tetanus toxin (TeNT) is produced by <i>C. tetani</i>, a spore-forming bacillus broadly spread in the environment. Although an inexpensive and safe vaccine is available, tetanus persists because of a lack of booster shots and variable responses to vaccines due to immunocompromised status...
Saved in:
Main Authors: | Tania Maria Manieri (Author), Daniela Yumi Takata (Author), Roselaine Campos Targino (Author), Wagner Quintilio (Author), João Victor Batalha-Carvalho (Author), Camila Maria Lucia da Silva (Author), Ana Maria Moro (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Advances and challenges in therapeutic monoclonal antibodies drug development
by: Mariana Lopes dos Santos, et al.
Published: (2018) -
Neutralizing activity of anti-respiratory syncytial virus monoclonal antibody produced in Nicotiana benthamiana
by: Nuttapat Pisuttinusart, et al.
Published: (2024) -
Characterization of neutralizing chimeric heavy-chain antibodies against tetanus toxin
by: Kexuan Cheng, et al.
Published: (2024) -
Production and Characterization of a Monoclonal Antibody Neutralizing Poliovirus Type 2
by: Morteza Kamalzadeh, et al.
Published: (2019) -
Anti-SARS-CoV-2 neutralizing monoclonal antibodies: clinical pipeline
by: Marco Tuccori, et al.
Published: (2020)